| Agensys initiates Phase I renal cancer trial - Trading Markets (press release) |
|
|
Trading Markets (press release)The single-agent, Phase I, open-label, dose-escalation study will evaluate the safety and tolerability of AGS-16M8F in patients with renal cancer and ... read more |